Zhengyi Chen

Dr. Zhengyi Chen

Case Western Reserve University, Cleveland, Georgia, USA
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2013 in BMC Public Health
Verified
Journal Article
Open access
PDF file
GWGuang-Rong Wang
Guang-Rong Wang
LLLi Li
Li Li
YPYi-Hui Pan
Yi-Hui Pan
GTGuo-Dong Tian
Guo-Dong Tian
WLWan-Long Lin
Wan-Long Lin
Nathan BergerNathan Berger
Nathan Berger
Background: Metabolic risk factors and abnormalities such as obesity and hypertension are rapidly rising among the Chinese population following China’s tremendous economic growth and widespread westernization of lifestyle in recent decades. Limited information is available about the current burden of metabolic syndrome (MetS) in China. Methods: We analyzed data on metabolic risk factors among 22,457 adults aged ≥ 32 years participating in the “Zhabei Health 2020” survey (2009–2010), a cross-sectional study of a representative sample of community residents in Zhabei District. We defined MetS using Chinese-specific cut-off points for central obesity according to consensus criteria recently endorsed by several international and national organizations in defining MetS in different populations worldwide. We used a multiple logistic regression model to assess the associations of potential risk factors with MetS. Results: The unadjusted prevalence of the MetS was 35.1% for men and 32.5% for women according to the consensus criteria for Chinese. The prevalence increased progressively from 12.1% among participants aged 32–45 years to 45.4% among those aged ≥ 75 years. Age, smoking, family history of diabetes, and education are significantly associated with risk of MetS. Conclusions: The MetS is highly prevalent and has reached epidemic proportion in Chinese urban adult community residents.

7 March 2018 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
GCGregory S. Cooper
Gregory S. Cooper
SMSanford D. Markowitz
Sanford D. Markowitz
ZCZhengyi Chen
Zhengyi Chen
MTMissy Tuck
Missy Tuck
JWJoseph E. Willis
Joseph E. Willis
LLLi Li
Li Li

10 November 2021 in Hypertension
Verified
Journal Article
Closed access
PDF file
JWJackson T. Wright
Jackson T. Wright
PWPaul K Whelton
Paul K Whelton
KJKaren C. Johnson
Karen C. Johnson
JSJoni K. Snyder
Joni K. Snyder
DRDavid M. Reboussin
David M. Reboussin
FGfor the SPRINT Research Group
for the SPRINT Research Group
The SPRINT (Systolic Blood Pressure Intervention Trial) results have influenced clinical practice but have also generated discussion regarding the validity, generalizability, and importance of the findings. Following the SPRINT primary results manuscript in 2015, additional results and analyses of the data have addressed these concerns. The primary objective of this article is to respond to key questions that have been raised.

9 November 2020 in Hypertension
Verified
Journal Article
Closed access
PDF file
MRMahboob Rahman
Mahboob Rahman
NPNishigandha Pradhan
Nishigandha Pradhan
ZCZhengyi Chen
Zhengyi Chen
RKRadhika Kanthety
Radhika Kanthety
RTRaymond R. Townsend
Raymond R. Townsend
JWJackson T. Wright
Jackson T. Wright
We evaluated the association between orthostatic hypertension and cardiovascular outcomes and the effect of intensive blood pressure (BP) control on cardiovascular outcomes in patients with orthostatic hypertension. Post hoc analyses of the SPRINT (Systolic Blood Pressure Intervention Trial) data were conducted; orthostatic hypertension was defined as increase in systolic BP≥20 mm Hg or increase in diastolic BP≥10 mm Hg with standing. Of 9329 participants, 1986 (21.2%) had orthostatic hypertension at baseline. Within the intensive treatment group, participants with orthostatic hypertension were at higher risk of developing the composite cardiovascular outcome (hazard ratio, 1.44 [95% CI, 1.1–1.87], P =0.007) compared with participants without orthostatic hypertension. Within the standard treatment group, there were no significant differences in cardiovascular outcome between participants with and without orthostatic hypertension. In participants with orthostatic hypertension, there was no statistically significant difference in risk of the composite cardiovascular outcome between the intensive and the standard BP treatment group (hazard ratio, 1.07 [95% CI, 0.78–1.47], P =0.68). In participants without orthostatic hypertension at baseline, the intensive treatment group was associated with a lower risk of the composite cardiovascular outcome (hazard ratio, 0.67 [95% CI, 0.56–0.79], P <0.0001). Orthostatic hypertension was associated with a higher risk of cardiovascular outcomes in the intensive and not in the standard treatment group; intensive treatment of BP did not reduce the risk of cardiovascular outcomes compared with standard treatment in patients with orthostatic hypertension. These post hoc analyses are hypothesis generating and will need to be confirmed in future studies.

28 May 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
ASAhlam Salameh
Ahlam Salameh
JMJessica McCabe
Jessica McCabe
MSMargaret Skelly
Margaret Skelly
KDKelsey Rose Duncan
Kelsey Rose Duncan
ZCZhengyi Chen
Zhengyi Chen
SPSvetlana Pundik
Svetlana Pundik
Gait deficits are often persistent after stroke, and current rehabilitation methods do not restore normal gait for everyone. Targeted methods of focused gait therapy that meet the individual needs of each stroke survivor are needed. Our objective was to develop and test a combination protocol of simultaneous brain stimulation and focused stance phase training for people with chronic stroke (>6 months). We combined Transcranial Direct Current Stimulation (tDCS) with targeted stance phase therapy using Virtual Reality (VR)-assisted treadmill training and overground practice. The training was guided by motor learning principles. Five users (>6 months post-stroke with stance phase gait deficits) completed 10 treatment sessions. Each session began with 30 min of VR-assisted treadmill training designed to apply motor learning (ML)-based stance phase targeted practice. During the first 15 min of the treadmill training, bihemispheric tDCS was simultaneously delivered. Immediately after, users completed 30 min of overground (ML)-based gait training. The outcomes included the feasibility of protocol administration, gait speed, Timed Up and Go (TUG), Functional Gait Assessment (FGA), paretic limb stance phase control capability, and the Fugl–Meyer for lower extremity coordination (FMLE). The changes in the outcome measures (except the assessments of stance phase control capability) were calculated as the difference from baseline. Statistically and clinically significant improvements were observed after 10 treatment sessions in gait speed (0.25 ± 0.11 m/s) and FGA (4.55 ± 3.08 points). Statistically significant improvements were observed in TUG (2.36 ± 3.81 s) and FMLE (4.08 ± 1.82 points). A 10-session intervention combining tDCS and ML-based task-specific gait rehabilitation was feasible and produced clinically meaningful improvements in lower limb function in people with chronic gait deficits after stroke. Because only five users tested the new protocol, the results cannot be generalized to the whole population. As a contribution to the field, we developed and tested a protocol combining brain stimulation and ML-based stance phase training for individuals with chronic stance phase deficits after stroke. The protocol was feasible to administer; statistically and/or clinically significant improvements in gait function across an array of gait performance measures were observed with this relatively short treatment protocol.

4 August 2022 in Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
ABAnna Crist Benson
Anna Crist Benson
ZCZhengyi Chen
Zhengyi Chen
NMNori Mercuri Minich
Nori Mercuri Minich
CTCurtis Tatsuoka
Curtis Tatsuoka
LFLydia Furman
Lydia Furman
AHAnna Maria Hibbs
Anna Maria Hibbs